DESTINY-PanTumor02
![Enhertu Boosts Survival in HER2+ Solid Tumors](https://pharmtales.com/wp-content/uploads/2023/07/Enhertu-increases-survival-in-solid-tumors-with-HER2.jpg)
Enhertu increases survival in solid tumors with HER2+
SG Tylor
AstraZeneca and Daiichi Sankyo have received a boost in their efforts to gain approval for Enhertu as a therapy for ...
AstraZeneca and Daiichi Sankyo have received a boost in their efforts to gain approval for Enhertu as a therapy for ...